Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer
about
Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target ProteinPrediction of Lymph Node Metastases in Gastric Cancer by Serum APE1 ExpressionElevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast CancerElevation of the Serum Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 in Coronary Artery Disease.APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.Secreted APE1/Ref-1 inhibits TNF-α-stimulated endothelial inflammation via thiol-disulfide exchange in TNF receptor.Human apurinic/apyrimidinic endonuclease 1.Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma.Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patientsAssociation between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement.Elevation of Serum APE1/Ref-1 in Experimental Murine Myocarditis.Evaluation of a newly developed quantitative determination kit for tumor marker CA15-3 with chemiluminescent assay.The extracellular role of DNA damage repair protein APE1 in regulation of IL-6 expression.Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1.
P2860
Q26745611-0D7D43DA-0EE8-49D8-803B-A70E920D96BBQ33820896-B1326CB5-9340-4C4C-81AB-D63471E616CCQ35711186-C95F9C80-E3A0-45F2-AE9A-F50CF93CB128Q36087446-28AB19C1-FB2F-4B65-A62A-73BC7E0B5591Q36186953-60CC5EBB-6C1C-4391-A93F-B3E9EA7EEE02Q36556271-4DE7C1D6-E551-4AC4-A6A1-CEDB56079F20Q36675119-58510750-2294-40F1-89BD-626FA3D3F45BQ37512952-532D2FF1-8CA2-4C70-B382-A67B2776B1C6Q37587416-448FAA60-B2FF-4976-95B2-46E1D150143AQ37684604-C01B9AB0-14EF-4E75-B279-15535E1265EBQ41117085-973FE0C7-3176-449C-B69A-A50FF91A0274Q47239549-E9622A39-237A-443A-9613-D145531AD717Q47961219-2A23EAB1-564F-45A4-8A99-240C3CE9697BQ48019408-773E1E54-555E-421B-89E5-0B6A006CAD46Q49379360-5F688A00-198E-4F24-A776-4B3F7B963F62
P2860
Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Serum APE1 autoantibodies: a n ...... in non-small cell lung cancer
@ast
Serum APE1 autoantibodies: a n ...... in non-small cell lung cancer
@en
Serum APE1 autoantibodies: a n ...... in non-small cell lung cancer
@nl
type
label
Serum APE1 autoantibodies: a n ...... in non-small cell lung cancer
@ast
Serum APE1 autoantibodies: a n ...... in non-small cell lung cancer
@en
Serum APE1 autoantibodies: a n ...... in non-small cell lung cancer
@nl
prefLabel
Serum APE1 autoantibodies: a n ...... in non-small cell lung cancer
@ast
Serum APE1 autoantibodies: a n ...... in non-small cell lung cancer
@en
Serum APE1 autoantibodies: a n ...... in non-small cell lung cancer
@nl
P2093
P2860
P1433
P1476
Serum APE1 autoantibodies: a n ...... in non-small cell lung cancer
@en
P2093
Meng-Xia Li
Shi-Heng Zhang
Xian-Feng Lu
Xiao-Jing Cao
Yu-Xin Yang
P2860
P304
P356
10.1371/JOURNAL.PONE.0058001
P407
P577
2013-03-05T00:00:00Z